Company / Operating Income per Share
CG Oncology, Inc. Operating Income per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.47
FY2025
5-year range
-$12.80 / -$1.83
FY2023-FY2025
Trend
-34.5%
vs FY2024
Sector context
#130 of 201
Health Care
What the data says
At $-2.47, CG Oncology, Inc.'s operating income per share ranks #130 of 201 in the Health Care sector. Improved from $-12.80 to $-2.47 over the past 2 years.
Based on SEC 10-K filings.
-2.47 in FY2025.
Improved from $-12.80 to $-2.47 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#130 of 201 in Health CareTop 65% of 201This company -$2.47 Sector average -$28.51
▼
+91.3% above sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 34.5% year-over-year.
- Ranks #130 out of 201 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.47 | -34.5% |
| FY2024 | -$1.83 | +85.7% |
| FY2023 | -$12.80 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026